BBRC researchers participate in the Alzheimer’s Association International Conference

A team of researchers of the Barcelonaβeta Brain Research Center (BBRC) presented the latest advances of the Alfa Study and the Barcelonaβeta Dementia Prevention Research Clinic, at the Alzheimer’s Association International Conference (AAIC) in Chicago, which took place from the 22nd to the 26th of July in Chicago.

The Director of the Alzheimer’s Prevention Program at the BBRC, Dr José Luis Molinuevo, presented the launch of the Barcelonaβeta Dementia Prevention Research Clinic and a new clinical trial that will start soon at the BBRC and the Hospital del Mar Research Institute (IMIM). Both projects were exposed at a satellite meeting of the World Wide Fingers consortium, in which several international initiatives on primary prevention of Alzheimer’s disease were presented. 

On the other hand, Molinuevo presented the advances of European Prevention of Alzheimer’s Dementia (EPAD) project in a meeting of the Alzheimer’s disease Neuroimaging Initiative (ADNI), and was invited to join the Neuroscience Steering Committee of the Biomarkers Consortium of the Foundation for the National Institutes of Health. He also participated in different meetings such as the symposium on biomarkers organized by Novartis and Amgen, the ADNI’s executive meeting, the executive meeting of TRIBEKA, the Alzheimer’s Prevention Committee meeting, and the editorial board meeting of the Alzheimer’s & Dementia: Translational Research & Clinical Interventions journal. 

The Director of the Pasqual Maragall Foundation, Dr Jordi Camí, also attended the conference, as well as Dr Juan Domingo Gispert, head of the Neuroimaging Research Group at BBRC, Gemma Salvadó, predoctoral researcher of the same group, and Dr Gonzalo Sánchez, member of the Clinical Research, Biomarkers and Risk Factors Research Group. They presented results related to the Alfa Study, funded by “la Caixa” Banking Foundation, in two oral communications and four posters. Furthermore, Gispert participated in meetings of the EPAD and the AMYPAD project, among others. 

The AAIC is the most prestigious international conference in the field of Alzheimer’s research.